Literature DB >> 20349068

Development of interstitial pneumonia in a patient with rheumatoid arthritis induced by isoniazid for tuberculosis chemoprophylaxis.

Kiyoshi Migita1, Tetsuya Umeno, Kana Miyagawa, Yasumori Izumi, Eisuke Sasaki, Tomoyuki Kakugawa, Masahiro Ito, Akitoshi Kinoshita, Taichiro Miyashita.   

Abstract

Here, we report a 56-year-old patient with rheumatoid arthritis (RA) who had been treated with methotrexate and sulfuasalazine, but the disease activity remained high. Therefore, we planned TNF-blocker treatment for this patient. A tuberculin skin test was positive, we started anti-tuberculosis (TB) chemoprophylaxis with isoniazid (INH). However, liver dysfunction was appeared after 2 weeks from the start of INH. Therefore, we discontinued INH transiently and tried the desensitization of INH. However, interstitial pneumonia was developed 2 weeks after the re-start of INH, we decided to stop the INH prophylaxis. Interstitial pneumonia was improved by corticosteroid treatments. This case report shows that INH-induced IP can be occurred during the course of anti-TB chemoprophylaxis in patients with RA.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20349068     DOI: 10.1007/s00296-010-1441-2

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  11 in total

1.  Pulmonary infiltrates and fever induced by isoniazid.

Authors:  E R Salomaa; E L Ruokonen; K Tevola; E Tala
Journal:  Postgrad Med J       Date:  1990-08       Impact factor: 2.401

2.  Isoniazid-induced interstitial pneumonia.

Authors:  M Miyai; T Tsubota; K Asano
Journal:  Respir Med       Date:  1989-11       Impact factor: 3.415

3.  Proposed [corrected] Japanese guidelines for the use of infliximab for rheumatoid arthritis.

Authors:  Nobuyuki Miyasaka; Tsutomu Takeuchi; Katsumi Eguchi
Journal:  Mod Rheumatol       Date:  2005       Impact factor: 3.023

4.  Methotrexate combined with isoniazid treatment for latent tuberculosis is well tolerated in patients with rheumatoid arthritis: experience from an urban arthritis clinic.

Authors:  A Mor; C O Bingham; M Kishimoto; P M Izmirly; J D Greenberg; S Reddy; P B Rosenthal
Journal:  Ann Rheum Dis       Date:  2007-08-20       Impact factor: 19.103

Review 5.  [A case of successful desensitization therapy for isoniazid-induced pneumonitis].

Authors:  Yoriko Nishizawa; Masahide Yasui; Chihiro Yamamori; Atsurou Tagami; Masaki Fujimura; Shinji Nakao
Journal:  Nihon Kokyuki Gakkai Zasshi       Date:  2004-07

6.  Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy.

Authors:  Frederick Wolfe; Kaleb Michaud; Janice Anderson; Kathy Urbansky
Journal:  Arthritis Rheum       Date:  2004-02

7.  Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis.

Authors:  T Takeuchi; Y Tatsuki; Y Nogami; N Ishiguro; Y Tanaka; H Yamanaka; N Kamatani; M Harigai; J Ryu; K Inoue; H Kondo; S Inokuma; T Ochi; T Koike
Journal:  Ann Rheum Dis       Date:  2007-07-20       Impact factor: 19.103

8.  [A case of isoniazid sodium methanesulfonate induced interstitial pneumonia].

Authors:  Hidekazu Matsushima; Yutaka Sugita; Tsutomu Yanagisawa; Mikio Ubukata; Tomonori Kurosawa; Fumika Yoshida; Minoru Kanazawa
Journal:  Kekkaku       Date:  2003-05

9.  Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report.

Authors:  Juan J Gómez-Reino; Loreto Carmona; Vicente Rodríguez Valverde; Emilio Martín Mola; Maria Dolores Montero
Journal:  Arthritis Rheum       Date:  2003-08

Review 10.  Pulmonary involvement in rheumatoid arthritis.

Authors:  J M Anaya; L Diethelm; L A Ortiz; M Gutierrez; G Citera; R A Welsh; L R Espinoza
Journal:  Semin Arthritis Rheum       Date:  1995-02       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.